Wedbush Reiterates Outperform on Ardelyx, Maintains $9 Price Target
Wedbush analyst Laura Chico reiterates Ardelyx (NASDAQ:ARDX) with a Outperform and maintains $9 price target.
Read original at benzingaStocks · News reference
Ardelyx Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $118.100M Miss $121.601M Estimate
Ardelyx (NASDAQ:ARDX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 12.5 percent increase over losses of $(0.08) per share from the same
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 6, 2026, 8:06 PM
- Checked
- Aug 6, 2026, 8:06 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — ARDELYX, INC. (ARDX)
Filed: 2026-08-17 AccNo: 0001193125-26-354026 Size: 142 KB Item 8.01: Other Events
Read original at edgarPiper Sandler Maintains Overweight on Ardelyx, Lowers Price Target to $15
Piper Sandler analyst Christopher Raymond maintains Ardelyx (NASDAQ:ARDX) with a Overweight and lowers the price target from $16 to $15.
Read original at benzingaCitigroup Maintains Buy on Ardelyx, Lowers Price Target to $11
Citigroup analyst Yigal Nochomovitz maintains Ardelyx (NASDAQ:ARDX) with a Buy and lowers the price target from $14 to $11.
Read original at benzinga